CAEB071B2201: A 24-month Randomized, Multicenter Study, Evaluating Efficacy, Safety, Tolerability and Pharmacokinetics of Sotrastaurin (STN) Combined with Tacrolimus (TAC) vs. a Tacrolimus/Mycophenolate Mofetil (MMF)-Based Control Regimen in De Novo Liver

Project: Research project

Project Details

StatusFinished
Effective start/end date3/22/109/30/13

Funding

  • Novartis Pharmaceuticals Corporation (CAEB071B2201)